Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting

References

• American Diabetes Association. Economic costs of diabetes in the U.S. in 2002.. Diabetes Care 2003;26:917-32
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24
   PubMed Web of Science ®Google Scholar
• Martyn CN, Hughes RAC. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-18
   PubMed Web of Science ®Google Scholar
• Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev 1999;7:245-52
   Google Scholar
• Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004;27:1591-7
   PubMed Web of Science ®Google Scholar
• Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-82
   PubMed Web of Science ®Google Scholar
• Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518-22
   PubMed Web of Science ®Google Scholar
• Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143-9
   PubMed Web of Science ®Google Scholar
• Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care 2003;26:1790-5
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg N, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-85
   PubMed Web of Science ®Google Scholar
• Stewart WF, Ricci JA, Chee E, et al. Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce. J Occup Environ Med 2007;49:672-9
   PubMed Web of Science ®Google Scholar
• Daousi C, Benbow SJ, Woodward A, et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med 2006;23:1021-4
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Knight G, Drury J, et al. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 1985;8:125-8
   PubMed Web of Science ®Google Scholar
• Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94
   PubMed Web of Science ®Google Scholar
• Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;19:2-8
   Web of Science ®Google Scholar
• Backonja M, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin 1998;16:776-89
   Web of Science ®Google Scholar
• Duby JJ, Campbell RK, Setter SM, et al. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-86
   PubMed Web of Science ®Google Scholar
• Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990;13:513-21
   PubMed Web of Science ®Google Scholar
• Barrett AM, Lucero MA, Le T, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007;8 (Suppl 2):S50-62 Review
   PubMed Web of Science ®Google Scholar
• Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997;20:1396-402
   PubMed Web of Science ®Google Scholar
• O'Brien JA, Shomphe LA, Kavanagh PL, et al. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 1998;21:1122-8
   PubMed Web of Science ®Google Scholar
• Brandle M, Zhou H, Smith BRK, et al. The direct costs of type 2 diabetes. Diabetes Care 2003;26:2300-4
   PubMed Web of Science ®Google Scholar
• Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999;159:1873-80
   PubMed Web of Science ®Google Scholar
• Mody R, Kalsekar I, Kavookjian J, et al. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. J Diabetes Complications 2007;21:75-83
   PubMed Web of Science ®Google Scholar
• Hartsfield CL, Korner EJ, Ellis JL, et al. Painful diabetic peripheral neuropathy in a managed care setting: patient identification, prevalence estimates, and pharmacy utilization patterns. Popul Health Manag 2008;11:317-28
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
   PubMed Web of Science ®Google Scholar
• Ritzwoller DP, Crounse L, Shetterly S, et al. The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord 2006;7:72
   PubMed Web of Science ®Google Scholar
• von Korff M, Deyo RA, Cherkin D, et al. Back pain in primary care. Outcomes at 1 year. Spine 1993;18:855-62
   Google Scholar
• Cherkin DC, Deyo RA, Volinn E, et al. Use of the International Classification of Diseases (ICD-9-CM) to identify hospitalizations for mechanical low back problems in administrative databases. Spine 1992;17:817-25
   PubMed Web of Science ®Google Scholar
• Fishman PA, Stang PE, Hogue SL. Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care. J Clin Psychiatry 2007;68:248-53
   PubMed Web of Science ®Google Scholar
• Harvey EC. Estimating regression models with multiplicative heteroscedasticity. Econometrica 1976;44:461-5
   Web of Science ®Google Scholar
• Pagano E, Bo S, Petrinco M, et al. Factors affecting hospitalization costs in type 2 diabetic patients. J Diabetes Complications 2009;23(1):1-6
   PubMed Web of Science ®Google Scholar